Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acromegaly, advertising, aging, anddenominator, BV, care, code, CRGK, Czech, dispute, distributor, doubtful, employee, entitled, EVOLEMA, evolving, Exhibit, expand, experienced, formulation, France, freight, Germany, good, Guokang, history, identification, incorporated, individual, inherent, isat, iv, LAI, long, MelphalanHydrochlorideFor, microsphere, neuroendocrine, numerator, obsolescence, octreotide, ofSeptember, ourCurrent, passing, pattern, Pharmathen, PRC, program, quarterly, reconciliation, Republic, restated, revenue, satisfy, startup, thiotepa, track, unsecured, version
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view